Data Foundry

Medical device recalls 2018

MicroVue CIC-C1q EIA — Class III medical device recall Z-1497-2018

Terminated recall by Diagnostic Hybrids, Inc., reported 2018-05-02, distributed nationwide. A component of the kit was found to contain bacterial contamination.

Recall numberZ-1497-2018
Product typeMedical device
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmDiagnostic Hybrids, Inc., Athens, OH, United States
Recall initiated2015-11-03
Classified2018-04-24
Reported by FDA2018-05-02
Terminated2020-08-28
DistributedNationwide (US)
Countries outside the USCH, HK, IN, JP
Quantity19 kits
Reason classesmicrobial contamination
Lot numbers051076
Model numbersA001

Product

MicroVue CIC-C1q EIA, Model A001. The MicroVue CIC-C1q EIA is for detection of circulating immune complexes (CIC) in human serum or plasma. The MicroVue CIC-C1q EIA is for detection of circulating immune complexes (CIC) in human serum or plasma. In certain disease states, immune complexes may initiate complement mediated damage of various organs and tissues. This activation of complement may begin a series of potentially destructive events including cell lysis, the production of anaphylatoxins, leukocyte stimulation and activation of macrophages. Major tissue damage can also occur when CIC fix to cell membranes as in some cases of glomerulonephritiscirculating immune complexes (CIC) in human serum or plasma.

Reason for recall

A component of the kit was found to contain bacterial contamination.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1497-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.